Update information

Update information

January 2019: Section 2 of the guidance updated because Thrombogenics has changed its name to Oxurion. Also, a new ready-diluted solution for injection replaces the original concentrate.

October 2013: Dose of ocriplasmin in section 2.1 corrected from 0.125 micrograms to 0.125 mg.

ISBN: 978-1-4731-0334-4

  • National Institute for Health and Care Excellence (NICE)